Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2003 Aug;58(8):680–685. doi: 10.1136/thorax.58.8.680

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

A White 1, S Gompertz 1, D Bayley 1, S Hill 1, C O'Brien 1, I Unsal 1, R Stockley 1
PMCID: PMC1746781  PMID: 12885984

Abstract

Background: Recent studies of the role of bacteria in chronic bronchitis have shown that bacterial colonisation is associated with enhanced inflammation and that purulent acute exacerbations of chronic bronchitis (AECB) are associated with bacteria and characterised by increased inflammation. Changes in bronchial inflammation in response to the success or failure of bacterial eradication following AECB were therefore studied.

Methods: Bacterial quantitative culture and sputum markers of inflammation (myeloperoxidase (MPO), neutrophil elastase, leukotriene B4 (LTB4), sol:serum albumin ratio, and secretory leukoprotease inhibitor) were measured in patients presenting with culture positive purulent AECB and repeated 10 days and 2 months later. 41 patients provided sputum sufficient for both bacteriology and assessment of inflammation at baseline and day 10, and 46 provided sufficient sample for bacteriology, 40 of which could also be analysed for inflammation at 2 months (when clinically stable).

Results: At day 10, 17 of the 41 patient samples had a positive bacterial culture. In the stable state, 18 of the 46 samples had a positive culture, but with a significantly lower bacterial load than at presentation. Although there was no difference between the groups at presentation, the concentration of MPO was lower (p<0.05) in those in whom bacteria were eradicated by day 10 than in those with persisting bacteria. The LTB4 concentration was similarly lower (p<0.001) in those in whom bacteria were eradicated than in those with persistent bacteria. In the stable clinical state the concentrations of both MPO and LTB4 were lower in those in whom bacteria were eradicated than in patients with persisting bacteria.

Conclusion: Resolution of bronchial inflammation following AECB is related to bacterial eradication. Those in whom bacteria continue to be cultured in their sputum have partial resolution of inflammation which may reflect continued stimulation by the reduced bacterial load.

Full Text

The Full Text of this article is available as a PDF (178.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amitani R., Wilson R., Rutman A., Read R., Ward C., Burnett D., Stockley R. A., Cole P. J. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol. 1991 Jan;4(1):26–32. doi: 10.1165/ajrcmb/4.1.26. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
  3. Bresser P., Out T. A., van Alphen L., Jansen H. M., Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):947–952. doi: 10.1164/ajrccm.162.3.9908103. [DOI] [PubMed] [Google Scholar]
  4. Bresser P., van Alphen L., Habets F. J., Hart A. A., Dankert J., Jansen H. M., Lutter R. Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J. 1997 Oct;10(10):2319–2326. doi: 10.1183/09031936.97.10102319. [DOI] [PubMed] [Google Scholar]
  5. Crooks S. W., Bayley D. L., Hill S. L., Stockley R. A. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000 Feb;15(2):274–280. doi: 10.1034/j.1399-3003.2000.15b09.x. [DOI] [PubMed] [Google Scholar]
  6. Donaldson G. C., Seemungal T. A. R., Bhowmik A., Wedzicha J. A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002 Oct;57(10):847–852. doi: 10.1136/thorax.57.10.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gompertz S., Bayley D. L., Hill S. L., Stockley R. A. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 2001 Jan;56(1):36–41. doi: 10.1136/thorax.56.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gompertz S., O'Brien C., Bayley D. L., Hill S. L., Stockley R. A. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001 Jun;17(6):1112–1119. doi: 10.1183/09031936.01.99114901. [DOI] [PubMed] [Google Scholar]
  9. Hiemstra P. S., Maassen R. J., Stolk J., Heinzel-Wieland R., Steffens G. J., Dijkman J. H. Antibacterial activity of antileukoprotease. Infect Immun. 1996 Nov;64(11):4520–4524. doi: 10.1128/iai.64.11.4520-4524.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hill A. T., Bayley D., Stockley R. A. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med. 1999 Sep;160(3):893–898. doi: 10.1164/ajrccm.160.3.9901091. [DOI] [PubMed] [Google Scholar]
  11. Hill A. T., Campbell E. J., Hill S. L., Bayley D. L., Stockley R. A. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000 Sep;109(4):288–295. doi: 10.1016/s0002-9343(00)00507-6. [DOI] [PubMed] [Google Scholar]
  12. Hirschmann J. V. Do bacteria cause exacerbations of COPD? Chest. 2000 Jul;118(1):193–203. doi: 10.1378/chest.118.1.193. [DOI] [PubMed] [Google Scholar]
  13. Kanner R. E., Anthonisen N. R., Connett J. E., Lung Health Study Research Group Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358–364. doi: 10.1164/ajrccm.164.3.2010017. [DOI] [PubMed] [Google Scholar]
  14. Khair O. A., Devalia J. L., Abdelaziz M. M., Sapsford R. J., Tarraf H., Davies R. J. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J. 1994 Dec;7(12):2109–2116. doi: 10.1183/09031936.94.07122109. [DOI] [PubMed] [Google Scholar]
  15. Li YingJi, Azuma Arata, Takahashi Satoru, Usuki Jiro, Matsuda Kuniko, Aoyama Akinori, Kudoh Shoji. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest. 2002 Dec;122(6):2137–2145. doi: 10.1378/chest.122.6.2137. [DOI] [PubMed] [Google Scholar]
  16. Murphy T. F., Sethi S., Klingman K. L., Brueggemann A. B., Doern G. V. Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis. 1999 Aug;180(2):404–409. doi: 10.1086/314870. [DOI] [PubMed] [Google Scholar]
  17. Naidich D. P., McCauley D. I., Khouri N. F., Stitik F. P., Siegelman S. S. Computed tomography of bronchiectasis. J Comput Assist Tomogr. 1982 Jun;6(3):437–444. doi: 10.1097/00004728-198206000-00001. [DOI] [PubMed] [Google Scholar]
  18. Patel I. S., Seemungal T. A. R., Wilks M., Lloyd-Owen S. J., Donaldson G. C., Wedzicha J. A. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002 Sep;57(9):759–764. doi: 10.1136/thorax.57.9.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Peterson M. W., Walter M. E., Nygaard S. D. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Biol. 1995 Dec;13(6):719–727. doi: 10.1165/ajrcmb.13.6.7576710. [DOI] [PubMed] [Google Scholar]
  20. Pye A., Stockley R. A., Hill S. L. Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol. 1995 Aug;48(8):719–724. doi: 10.1136/jcp.48.8.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scott L. J., Ormrod D., Goa K. L. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs. 2001;61(10):1455–1500. doi: 10.2165/00003495-200161100-00008. [DOI] [PubMed] [Google Scholar]
  22. Seemungal T. A., Donaldson G. C., Paul E. A., Bestall J. C., Jeffries D. J., Wedzicha J. A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418–1422. doi: 10.1164/ajrccm.157.5.9709032. [DOI] [PubMed] [Google Scholar]
  23. Sethi S., Murphy T. F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001 Apr;14(2):336–363. doi: 10.1128/CMR.14.2.336-363.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sethi Sanjay, Evans Nancy, Grant Brydon J. B., Murphy Timothy F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002 Aug 15;347(7):465–471. doi: 10.1056/NEJMoa012561. [DOI] [PubMed] [Google Scholar]
  25. Stockley R. A., Bayley D. L. Validation of assays for inflammatory mediators in sputum. Eur Respir J. 2000 Apr;15(4):778–781. doi: 10.1034/j.1399-3003.2000.15d24.x. [DOI] [PubMed] [Google Scholar]
  26. Stockley R. A., Bayley D., Hill S. L., Hill A. T., Crooks S., Campbell E. J. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax. 2001 May;56(5):366–372. doi: 10.1136/thorax.56.5.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stockley R. A., O'Brien C., Pye A., Hill S. L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000 Jun;117(6):1638–1645. doi: 10.1378/chest.117.6.1638. [DOI] [PubMed] [Google Scholar]
  28. Woolhouse I. S., Hill S. L., Stockley R. A. Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis. Thorax. 2001 Dec;56(12):947–953. doi: 10.1136/thorax.56.12.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yi K., Sethi S., Murphy T. F. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J Infect Dis. 1997 Nov;176(5):1247–1252. doi: 10.1086/514119. [DOI] [PubMed] [Google Scholar]
  30. van Wetering S., van der Linden A. C., van Sterkenburg M. A., Rabe K. F., Schalkwijk J., Hiemstra P. S. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Investig Med. 2000 Sep;48(5):359–366. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only Tables]
thorax_58_8_680__index.html (1.4KB, html)
thorax_58_8_680__1.pdf (78.8KB, pdf)
thorax_58_8_680__2.pdf (79KB, pdf)

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES